અચ્યુત હેલ્થકેર શેર પ્રાઇસ

અચ્યુત હેલ્થકેર ઇન્વેસ્ટમેન્ટ રેટિંગ

• માસ્ટર રેટિંગ:

• Achyut Healthcare has an operating revenue of Rs. 13.15 Cr. on a trailing 12-month basis. An annual revenue growth of 109% is outstanding, Pre-tax margin of 12% is healthy, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 7% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 16% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 17 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.